(PharmaNewsWire.Com, January 22, 2018 ) The Europe Vascular Imaging market is anticipated to grow at a 6.43% CAGR from 2016 to 2021 and it is estimated that the Europe market was valued at USD 1.13 billion in 2016 and is expected to reach USD 1.54 billion by 2021.
Vascular Imaging Market Vascular imaging is a key element of a comprehensive stroke diagnosis and cause-based therapy. The test of vascular imaging detects in assessing the blood circulation through the veins and vesicles which helps the surgeons in performing the surgeries. Various imaging techniques, such as X-ray, Magnetic Resonance Imaging (MRI), Computerized Tomography (CT) scans, ultrasound, and fluoroscopy (moving X-ray images using contrast dye), are used to observe and record the state of blood vessels and other organs so that diagnosis and intervention can be achieved.
Europe Vascular Imaging Market Outlook:
The demand for vascular imaging systems is expected to witness highest growth rate over the forecast period due to growth in the number of patients suffering from cardiovascular diseases (CVD). Increasing number of cardiovascular diseases is expected to drive the demand for vascular imaging systems required for the diagnosis of the CVDs. Introduction of new vascular imaging systems and increasing adoption of minimally invasive surgeries is expected to increase the demand for vascular imaging systems over the coming years. Moreover, technological advancements in imaging systems like the introduction of 3D imaging over 2D imaging is expected to boost the adoption rate of vascular imaging systems. Angiography is widely performed in old people; increase in the Europe geriatric population is also expected to raise the demand for vascular imaging systems. However, the high price of the systems and lack of expertise to handle imaging equipment and pricing pressure on the manufacturers due to fierce competition among market participants may have negative impact on the growth of the market. Moreover, because of a large number of hospital network operating under one organization, these networks can influence the price of the medical devices with the manufacturers of vascular imaging systems and in turn reduce their profitability margins.
The Europe market for Vascular Imaging market is segmented into Procedure, Technology, Application and End User. On the basis of procedure, it is segmented into Coronary Angiography, Peripheral, Cerebral and Angiography. Coronary angiography segment is anticipated to account for the largest share of the market. Increase in the prevalence of CVDs and increase in geriatric population are major factors driving the growth this market segment. On the basis of Technology, it is segmented into CT, MRI, X-Ray, Ultrasound, and Nuclear Imaging. The MRI segment is expected to dominate this market segment. The increase in the use of MRI in vascular imaging is mainly due to its minimally invasive nature and high efficacy and increasing prevalence of cardiovascular diseases are the key factors driving the growth of this segment. On the basis of Application, it is segmented into Diagnostic and Therapeutic. On the basis of End User, it is segmented into Hospital and Clinical Laboratory. Hospitals are the largest end users of vascular imaging systems. It is also projected to register the highest growth. This can be credited to technological development, increase in the healthcare expenditure, and increase in usage of imaging systems in hospitals and hybrid ORs.
The market is analyzed under various regions namely Germany, Italy, France, U.K. and Spain. Europe is expected to be the second most lucrative market in the vascular imaging systems market because of the high investment in healthcare industry. Increase in the number of interventional surgeries and growing number of cardio – vascular diseases in Europe is expected to create high opportunity for vascular imaging systems market
The market is dominated by companies like:
Siemens Healthineers (Germany), GE Healthcare (U.K.), N.V. (Netherlands), Esaote SpA (Italy), Pie Medical Imaging (Netherlands), Xograph Healthcare (U.K.), and Piur imaging GmbH (Austria).
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
